FAQ — USEFUL INFORMATION ABOUT 714X

714X is a non-toxic health product that aims to restore the body's optimal potential for action in its immune defense without the risk of negative side effects. It can restore the biological terrain either when the immune defense is deficient or when it is too active.

In fact, the scientific name of this product is trimethylbicyclonitraminoheptane chloride. To facilitate common use, this fancy name (714X) was inspired by the initials of the inventor, GN: the G being the 7th letter of the alphabet and the N being the 14th letter. As for the X, being the 24th letter, it corresponds to the last two digits of the year of birth of the inventor.

714X is a water-based liquid product containing mineral salts, including sodium chloride and ammonium chloride, alcohol and camphor. The visual appearance of the 714X is a clear, colourless liquid.

It works in two ways:

1- by liquefying lymph, which allows for a better elimination of metabolic toxins circulating in the blood (detoxification process);

2- by acting directly on blood cells, especially on white blood cells involved in immune modulation (regulating and repair processes).

In short, it acts in the biological field to activate or restrict the immune system to restore biological homeostasis.

Yes, 714X is safe.

714X is a synthesis product that has been validated for its non-toxicity at each stage of its design, using light microscopy as a control. Therefore, it carries no risk when introduced into a living organism.

In Canada, 714X was integrated into Health Canada's Emergency Drug Access Program in December 1989. Since 1995, this program has been called the Special Access Program (SAP).

In this process of acceptance of the product, the Canadian government at the same time declared, after laboratory analysis, that the product met sterility standards. Also, they established the list of biochemical constituents of the product.

In addition, several independent research groups have validated certain attributes of the 714X.

Notably, in 1978, Bio-Research Laboratories Ltd. demonstrated that 714X was non-toxic even at high doses.

In 1999, Dana-Farber Cancer Institute (after an in vitro immunological assay) demonstrated, among other things, that 714X is a potent anti-inflammatory product capable of inducing activating reactions of the immune system or slowing it down as appropriate.

Yes, but it is essential to understand that our statistical data evaluates the impact of the product not on a group average, but on the person who uses it.

As a result, it is impossible to establish group efficacy statistics since this product works individually in human biology. It never targets a specific pathology, as is the case for pharmaceutical products, such as prescription or over-the-counter drugs.

However, we can say that the action of the 714X, in 100% of cases, comes down to these two functions:

1- It liquefies the lymph in the first 5 to 10 days of use: this is the cleansing process.

2- It acts upon the blood cells, allowing them to resume their biological normality in their respective functions: this is the process of cellular repair.

This observation was made possible by microscopic monitoring of the live blood during the preclinical evaluation period prior to the marketing of 714X.

The action of 714X on your metabolism will manifest itself subjectively from the first 15 days (better quality of life, vitality, appetite, etc.).

In a measurable and observable way, conventional tests can be carried out by a health professional after 3 cycles of use. A minimum of 6 to 8 cycles is necessary to gradually restore the state of each person's biological terrain.

It is the state of each person's biological terrain which will determine the speed of the cellular repair process.

Since 714X works directly on lymphatic circulation and blood, it may be used in several circumstances related to the immune system to provide some regulation.

Due to its special status in Canada, the product has been widely authorized by Health Canada in several diagnoses of degenerative diseases, such as cancer, multiple sclerosis and Alzheimer’s disease, as well as for autoimmune diseases, such as lupus erythematosus, mastocytosis and other inflammatory conditions.

714X is given by perinodal injection to reach the large lymphatic circulation.

In some cases, it is also administered, in a complementary way to injections, by ultrasonic nebulizer to reach the small lymphatic circulation via the lymph nodes of the respiratory system

The use of the nebulizer is justified when the disorder is in the right upper part of the body.

No, there is absolutely no risk of self-injection for many reasons:

- The 714X product is sterile and non-toxic.

- Since this product does not contain any foreign proteins, it does not present any risk of allergies.

- If the aseptic precautions are well respected as described in the manufacturer's protocol, it’s totally safe to self-inject the 714X product.

This product has no side effects. However, in certain cases, there may be a normal cleansing process for 5 to 10 days depending on the state of each person's biological terrain. These symptoms are temporary and testify to the positive action of the product.

714X can be used alone. It can also be used without interaction in combination with various prescribed products. In addition, it can also be used in combination with natural health products.

Anyone can use 714X: children, teenagers, adults and elderlies.

Yes, it is possible to order the product for someone other than yourself. However, it is essential to ensure the consent of the person who will use the product and the proper understanding of how it works.

The product can be exported to most countries. Each country has a specific import procedure for its residents who import health products for personal use. We invite you to check the import procedure in force in your country.

The sale of 714X is restricted in Canada. If you are a Canadian resident, please consult the legal procedure in force in Canada to access the 714X product manufactured by CERBE Laboratory.